Norda ASA Stock Oslo Bors
Equities
NORD
NO0010285190
Biotechnology & Medical Research
Sales 2021 | 139M 12.81M | Sales 2022 | 128M 11.77M | Capitalization | 204M 18.74M |
---|---|---|---|---|---|
Net income 2021 | 82M 7.54M | Net income 2022 | 100M 9.2M | EV / Sales 2021 | 0.22 x |
Net cash position 2021 | 159M 14.6M | Net cash position 2022 | 257M 23.61M | EV / Sales 2022 | -0.41 x |
P/E ratio 2021 * |
-
| P/E ratio 2022 |
-
| Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 6.26% |
Managers | Title | Age | Since |
---|---|---|---|
Frode Westvold
CEO | Chief Executive Officer | - | 13-04-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 13-06-19 | |
Chairman | 52 | 12-06-20 | |
Director/Board Member | - | - |
1st Jan change | Capi. | |
---|---|---|
-16.10% | 11.41B | |
-30.20% | 2.3B | |
-14.31% | 2.16B | |
-26.03% | 1.56B | |
+36.95% | 1.19B | |
-2.40% | 760M | |
-19.00% | 506M | |
-38.57% | 444M | |
+13.72% | 339M |